| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | EP1017721B1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/25/2009 | EP0852587B1 Synthetic peptides that inhibit il-6 activity |
| 02/25/2009 | CN201197815Y Loratadine and pseudoephedrine sulfate sustained and controlled release capsules |
| 02/25/2009 | CN101375160A Potentiation of apoptosis by monoclonal antibodies |
| 02/25/2009 | CN101374839A Azaindoles useful as inhibitors of janus kinases |
| 02/25/2009 | CN101374823A Organic compounds |
| 02/25/2009 | CN101374821A 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as S1P1 receptor agonists, immunosuppresssive and anti-inflammatory agents |
| 02/25/2009 | CN101374509A Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production |
| 02/25/2009 | CN101372513A SG fusion protein |
| 02/25/2009 | CN101372499A Novel medicament having antiinflammatory activity |
| 02/25/2009 | CN101371923A BAFF receptor (BCMA), an immunoregulatory agent |
| 02/25/2009 | CN101371922A Water-bearing liquid transformation reaction vaccine formulation for oral mucous membrane administration |
| 02/25/2009 | CN101371918A Novel use of oxidation resistance dipeptide in fish extract polypeptide |
| 02/25/2009 | CN101371915A Method for preparing minor decoction of Bupleurum formulation |
| 02/25/2009 | CN101371907A Ultra-high biomass all-around ordered high biological activity immunoincompetence disease Chinese medicine preparation |
| 02/25/2009 | CN101371906A Ultra-high biomass ordered high biological activity multi-polymer Chinese medicine preparation |
| 02/25/2009 | CN101371891A Composition of ginseng, astragalus and Ganoderma lucidum and production method |
| 02/25/2009 | CN101371851A Immunity enhancement use of wintercherry fruit polysaccharide |
| 02/25/2009 | CN100464566C Method and equipment of changed digital color image |
| 02/25/2009 | CN100463674C Oral cavity quick dissolved film containing civeran and method for preparing the same |
| 02/25/2009 | CN100463613C Preparation method for whole aloe arborensis health food |
| 02/24/2009 | US7495114 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/24/2009 | US7495086 TWEAK receptor |
| 02/24/2009 | US7495085 Immunoglobulin for use in diagnosis, prevention and treatment of allergies, autoimmune, inflammatory and cell proliferative disorders |
| 02/24/2009 | US7495081 Framework patched anti-CD20 antibody |
| 02/24/2009 | US7495018 An enzyme inhibitor of p38 MAP kinase, an antagonist of tumor necrosis factors or adenosine receptor, a thiazole with the 5-pyridyl group derivatives |
| 02/24/2009 | US7494973 Therapeutic fibrin-derived peptides and uses thereof |
| 02/24/2009 | US7494808 Methods and interferon deficient substrates for the propagation of viruses |
| 02/24/2009 | US7494785 Recombinant subunit vaccine |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | US7494655 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome |
| 02/24/2009 | US7494653 Inoculating a patient with an effective amount of PcrV antigen; monoclonal antibodies specific for the PcrV antigen |
| 02/24/2009 | CA2443543C Supplementation of equine feedstuffs |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2360437C Method of acquiring immunological tolerance |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/24/2009 | CA2316972C Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 02/24/2009 | CA2245497C Peptide immunogens for vaccination against and treatment of allergy |
| 02/24/2009 | CA2214633C Antibody purification by low-ph hydrophobic interaction chromatography |
| 02/24/2009 | CA2194236C Helicobacter proteins and vaccines |
| 02/24/2009 | CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 02/19/2009 | WO2009023653A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | WO2009023269A2 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-b[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases |
| 02/19/2009 | WO2009022720A1 Five-membered heterocyclic compound |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009021696A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | WO2009021289A1 Potassium channel inhibitors |
| 02/19/2009 | WO2008152423A3 Treatment of inflammation or autoimmune diseases with sulphated compounds |
| 02/19/2009 | WO2008088422A3 Toxin peptide therapeutic agents |
| 02/19/2009 | WO2008057246A3 Method for treating inflammatory disorders |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048328 Compound Comprising Prodigiosin From Serratia Macescence B-1231 Kctc 0386Bp for Prevention and Treatment of Acute Graft-Versus-Host Disease |
| 02/19/2009 | US20090048285 Pyrrolopyridines Useful in the Treatment of Inflammation |
| 02/19/2009 | US20090048275 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
| 02/19/2009 | US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048235 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048222 Triaza Compound Immunoregulatory Agents |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048181 Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis |
| 02/19/2009 | US20090048165 Anti-hiv agent |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/19/2009 | US20090047324 Medical Devices Containing Rapamycin Analogs |
| 02/19/2009 | US20090047306 Adjuvant compositions |
| 02/19/2009 | US20090047293 immunization; comprised of a fusion protein; bioterrorism; plague |
| 02/19/2009 | US20090047292 Graft rejection suppressors |
| 02/19/2009 | US20090047289 Osteopontin Specific Antibodies and Methods of Use Thereof |
| 02/19/2009 | US20090047272 Compositions with Modified Nucleases Targeted to Viral Nucleic Acids and Methods of Use for Prevention and Treatment of Viral Diseases |
| 02/19/2009 | US20090047264 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 02/19/2009 | US20090047250 Methods for treating or preventing neuroinflammation or autoimmune diseases |
| 02/19/2009 | US20090047242 Conditioned blood composition and method for its production |
| 02/19/2009 | US20090047234 Compositions for nasal delivery |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | CA2696630A1 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/19/2009 | CA2695753A1 Compounds useful as protein kinases inhibitors |
| 02/19/2009 | CA2695475A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/18/2009 | EP2026073A1 Diagnostics and therapeutics for macular degeneration-related disorders |
| 02/18/2009 | EP2025749A1 Humanized anti-human osteopontin antibody |
| 02/18/2009 | EP2025682A2 Human endokine alpha |
| 02/18/2009 | EP2025680A1 Degranulation inhibitor |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2025345A1 KIM-1 antagonists and use to modulate immune system |
| 02/18/2009 | EP2024370A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes |
| 02/18/2009 | EP2023957A2 Oral liquid loratadine formulations and methods |
| 02/18/2009 | EP2023955A2 Administration of anti-cd3 antibodies in the treatment of autoimmune diseases |
| 02/18/2009 | EP1539727B1 Compounds, compositions, and methods for treating cellular proliferative diseases |
| 02/18/2009 | EP1458757B1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 02/18/2009 | EP1448281B1 Therapeutic coating for an intravascular implant |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | EP1027063B1 Mannose receptor bearing cell line and antigen composition |